Preliminary Consequences of Blood Pressure Management and Blood Homocysteine Levels with Perindopril in Newly Diagnosed Hypertensive Patients in the Vietnamese Population

Table 5

Comparison of blood Hcy levels before and after treatment with perindopril.

		Homocysteine	n	Mean ± SD	Mean difference 95% CI
Homocysteine		Pretreatment	105	17.88 ± 6.03	4.33 (3.69–4.97)	<0.001
		Posttreatment	105	13.55 ± 4.01
Gender	Male	Pretreatment	29	19.98 ± 4.68	4.86 (3.65–6.07)	<0.001
		Posttreatment	29	15.12 ± 3.07
	Female	Pretreatment	76	17.08 ± 6.31	4.12 (3.36–4.89)	<0.001
		Posttreatment	76	12.96 ± 4.18
Age	≥60	Pretreatment	72	18.61 ± 5.72	4.52 (3.76–5.28)	<0.001
		Posttreatment	72	14.09 ± 3.92
	<60	Pretreatment	33	16.28 ± 6.44	3.91 (2.68–5.15)	<0.001
		Posttreatment	33	12.37 ± 4.02
Diabetes	Yes	Pretreatment	49	17.31 ± 6.59	4.07 (3.10–5.03)	<0.001
		Posttreatment	49	13.24 ± 4.31
	No	Pretreatment	56	18.38 ± 5.49	4.56 (3.68–5.43)	<0.001
		Posttreatment	56	13.82 ± 3.75

Paired-sample t-test.